🇺🇸 FDA
Patent

US 8962797

Halogenated compounds for photodynamic therapy

granted A61KA61K31/403A61K31/404

Quick answer

US patent 8962797 (Halogenated compounds for photodynamic therapy) held by NANOQUANTUM SCIENCES, INC. expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
NANOQUANTUM SCIENCES, INC.
Grant date
Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/403, A61K31/404, A61K31/438, A61K41/0057